ALN-AGT01

· Alnylam Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALN-AGT01, covering 2024-12-27 to 2024-12-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension [Phase 2]